Content
Coinbase More Accessible In Canada Now, Interac E-Transfers Enabled
Article By:
The Tokenist
Read
Monday, August 14, 2023 8:25 AM EDT
Coinbase added several new features to its Canadian platform and announced it's "official launch" in the region.
In this article: COIN
When A Secondary Stock Offering Is Great News
Article By:
Tim Plaehn
Read
Monday, August 14, 2023 8:15 AM EDT
A secondary stock offering comes with a sharp drop in a company’s stock price. Rapid price declines make investors nervous, wondering if the company is facing troubles.
In this article: HTGC
The AI-Driven Stock Market: A Ticking Time Bomb?
Article By:
Shelly Palmer
Read
Sunday, August 13, 2023 10:01 AM EDT
As we stand on the precipice of an overwhelmingly AI-driven financial world, we must ask: Are we prepared for the potential fallout? Gary Gensler has sounded the alarm bells.
ESPN Bets On Sports Betting
Article By:
Felix Salmon
Read
Sunday, August 13, 2023 8:19 AM EDT
Felix Salmon and Elizabeth Spiers are joined by Cardiff Garcia to discuss ESPN’s big new investment in sports betting. They break down the state of a lawsuit over how much UFC fighters get paid.
China’s Deflation Dilemma – Coming To The US?
Article By:
Kurt Kallaus
Read
Sunday, August 13, 2023 4:35 AM EDT
US inflation and the related worker shortage have clearly been the top concerns for small businesses for the past 2 years. The US and global stimulus efforts created artificial demand far in excess of supply which caused these concerns to manifest.
In this article: SPX
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
Article By:
ChinaBio® Today
Read
Saturday, August 12, 2023 2:39 PM EDT
BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies raised $100 million in a private placement.
US And EU Corporations Slam The Brakes On Demand For Business Loans
Article By:
Mish Shedlock
Read
Wednesday, August 9, 2023 7:00 AM EDT
Both the US and Europe have seen massive drops in demand for bank loans. Meanwhile, the Fed said they no longer expect a recession.
Book Review: The Inside Scoop
Article By:
Saj Karsan
Read
Wednesday, August 9, 2023 4:00 AM EDT
Two friends, Ben and Jerry, took their ice cream brand from zero to one of the major leaders in the super-premium ice cream market. The Inside Scoop is the story of that company as told by the CEO who took over from them.
In this article: UL
Weekly Market Pulse: Expect The Unexpected
Article By:
Joseph Calhoun
Read
Monday, August 7, 2023 8:36 AM EDT
The stock market was down a little over 2% last week in what may be the start of a larger correction. Or not. Technically one can make a case for more downside to the 50 day moving average, a pullback of 5%, and then a resumption of the uptrend.
Oil And Natural Gas: Oil Remains High Above $82.00
Article By:
Finance Brokerage
Read
Monday, August 7, 2023 7:24 AM EDT
During the Asian trading session, the oil price was retreating from the $83.26 level. We are currently at the $82.40 level, and based on today’s consolidation, we can expect a continued pullback to the $82.00 level.
Recession Forecast Still Correct For Late 2023 Or Early 2024
Article By:
Bill Conerly
Read
Sunday, August 6, 2023 11:44 AM EDT
Could the delaying factors ease the economy into a soft landing? That looks more plausible than ever before, but forecasting “this time it’s different” usually turns out badly.
Soaring Structure Investment Makes Up For Slowing Consumption As GDP Grows At 2.4 Percent In Q2
Article By:
Angry Bear
Read
Sunday, August 6, 2023 9:43 AM EDT
The economy grew at a 2.4 percent annual rate in the second quarter, as strong investment growth offset slower consumption growth. Consumption spending grew at just a 1.6 percent annual rate, down from a 4.6 percent rate in the first quarter.
Week In Review: Mundipharma Considers $1 Billion Sale Of China Operations
Article By:
ChinaBio® Today
Read
Saturday, August 5, 2023 2:19 PM EDT
Mundipharma is considering selling its China operations in a deal that could be worth $1 billion. Additionally, Oramed Pharma plans to form a $60 million JV with Hefei Tianhui Biotech to commercialize Oramed's oral drug delivery products globally.